What is the Impact Factor of Blood Coagulation & Fibrinolysis?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Blood Coagulation & Fibrinolysis is 1.00, ranking in quartile Q4 of Web of Science (SCIE).

Is Blood Coagulation & Fibrinolysis indexed in Web of Science or Scopus?

Yes, Blood Coagulation & Fibrinolysis is indexed in Web of Science (SCIE, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.402 (Q3) and an H-index of 81.

Who publishes Blood Coagulation & Fibrinolysis and what is the Article Processing Charge (APC)?

Blood Coagulation & Fibrinolysis is published by Lippincott Williams and Wilkins Ltd.. The estimated Article Processing Charge (APC) is approximately $2,757 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Blood Coagulation & Fibrinolysis?

The official ISO-4 abbreviation of Blood Coagulation & Fibrinolysis is "BLOOD COAGUL FIBRIN" with common acronym "bcf". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q4Scopus Q3SCImago #14,161Hybrid

Blood Coagulation & Fibrinolysis

Acronym:bcf

•

Abbreviation (ISO):BLOOD COAGUL FIBRIN

•

Identifier (ISSN):0957-5235(Print)/1473-5733(Online)

•

Publisher:Lippincott Williams and Wilkins Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

1↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Blood Coagulation & Fibrinolysis

WoS Q4

Annual Impact Factor Metric

Current (2026):1

Scopus SJR & RankScopus Q3

0.402

#14,161

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

81 papers with at least that number of citations each

WoS: SCIE / JCRQ4

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

93articles/year

10.58% Gold OA•88.24% Original Research

Aims & Scope

Blood Coagulation & Fibrinolysis is an international fully refereed journal that features review and original research articles on all clinical, laboratory and experimental aspects of haemostasis and thrombosis. The journal is devoted to publishing significant developments worldwide in the field of blood coagulation, fibrinolysis, thrombosis, platelets and the kininogen-kinin system, as well as dealing with those aspects of blood rheology relevant to haemostasis and the effects of drugs on haemostatic components

Topics Covered (Recognized by AI)

Medicine96.2%Internal medicine89.2%Biology87.2%Chemistry66%Psychology61.8%Biochemistry61.6%Surgery60.9%Psychiatry59.5%Immunology56.2%Genetics55.5%Platelet38.1%Pathology28.8%Endocrinology27%Cardiology26.8%Coagulation26.2%Physics24.8%Thrombosis23.2%Gastroenterology22.1%

Primary Research Areas

Medicine Hematology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

HEMATOLOGY

Rank87/103

IndexSCIE

JCISCIE2026

HEMATOLOGY

Rank83/103

IndexSCIE

Category	Index	Rank	Quartile
HEMATOLOGY	JCRSCIE	87/103	Q4
HEMATOLOGY	JCISCIE	83/103	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1

Articles / Year52

Total Citations3

2025

IF1.1

Articles / Year64

Total Citations38

2024

IF1.2

Articles / Year63

Total Citations130

2023

IF1.1

Articles / Year85

Total Citations259

2022

IF1.061

Articles / Year81

Total Citations489

Year	Impact Factor	Articles / Year	Total Citations
2026	1	52	3
2025	1.1	64	38
2024	1.2	63	130
2023	1.1	85	259
2022	1.061	81	489
2021	1.276	112	603
2020	1.203	114	785
2019	1.12	88	611
2018	1.119	98	1,168
2017	—	75	812
2016	—	157	1,983
2015	—	225	2,501

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #14,161Scopus Q3SCImago Profile

Scopus Coverage:1990-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q3

0.402

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

0.97

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,757 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations286

3-Year Documents248

Citable Documents234

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate55.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ3

Medicine (miscellaneous)Q3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区HEMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Blood Coagulation & Fibrinolysis (acronym: bcf, abbr: BLOOD COAGUL FIBRIN, ISSN: 0957-5235) is a peer-reviewed international scholarly journal in the field of Medicine, published by Lippincott Williams and Wilkins Ltd. in United States since 1990. The periodical holds a Journal Impact Factor (JIF) of 1.00, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.402 (Q3), an H-index of 81.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 93 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,757 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.